John Grumitt, vice president of Diabetes UK and chief executive of Changing Health, says digital health innovators can work with big pharma to address medical needs.
Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment